Pune-based startup Mylab Discovery Solutions has joined forces with the US-based Hemex Health, a medical diagnostic device company focused on creating life-changing global health products, to develop next-generation diagnostic solutions for the Point-of-Care (POC) testing of coronavirus and other diseases.
Under the technology partnership, Mylab will develop test assays and Hemex will provide its Gazelle POC testing platform and expertise.
The portable diagnostic device and tests assays will help in testing at any location, in a wide range of environmental conditions, and without the need to transport the sample, enabling quick results for the patients.
Together, the companies will develop Fluorescence Immunoassay (FIA) and Electrophoresis-based diagnostic solutions. These tests are more sensitive than the normal rapid antigen tests and have fewer false negatives. The diagnostic solution will be jointly introduced in the international markets including the US, Europe and Asia.
Commenting on the partnership, Hasmukh Rawal, MD, Mylab Discovery Solutions, said, “Together with Mylab’s accurate FIA test kits, we can make testing available anywhere – from a small village without electricity to an international airport. We believe this partnership will help India and the world prevent subsequent waves of coronavirus”.
The companies expect the first product from this technology partnership to be launched by November 2021.
